Gilead Sciences Inc v Idenix Pharmaceuticals Inc

Counsel to Gilead Sciences Inc in the Federal Court and Federal Court of Appeal (leave to SCC denied) proceeding in respect of sofosbuvir, successfully invalidating Idenix’s ‘191 patent and maintaining Gilead’s ‘657 patent. (Prior to joining Lenczner Slaght.)